Description
Product details
RUDIX FCM IV is a sterile intravenous iron formulation containing Ferric carboxymaltose, designed for the rapid and effective treatment of iron deficiency and iron deficiency anemia (IDA). It is specifically developed for patients who require fast iron replenishment, cannot tolerate oral iron supplements, or have conditions where oral iron therapy is ineffective. Iron deficiency remains one of the most common nutritional deficiencies worldwide, affecting women, children, patients with chronic diseases, and individuals recovering from surgery. RUDIX FCM IV provides a modern, safe, and convenient approach to restoring iron stores efficiently under medical supervision. Product Overview Product Name: RUDIX FCM IV Generic Name: Ferric Carboxymaltose Injection Dosage Form: Intravenous injection / infusion Route of Administration: IV use only Indication: Treatment of iron deficiency and iron deficiency anemia RUDIX FCM IV is formulated using advanced iron-carbohydrate complex technology that allows controlled and gradual release of iron into the bloodstream. This reduces the risk of free iron toxicity while ensuring effective replenishment of hemoglobin levels and iron stores. What is Ferric Carboxymaltose? Ferric carboxymaltose is a next-generation intravenous iron complex. Unlike traditional iron salts, it allows the administration of larger single doses in a shorter duration, reducing the need for multiple hospital visits. The iron core is tightly bound within a carbohydrate shell, enabling controlled release and minimizing adverse reactions compared to older IV iron formulations. Once administered, iron from ferric carboxymaltose is taken up by the body's iron-binding proteins and transported to the bone marrow, where it supports red blood cell production and improves hemoglobin levels. Uses of RUDIX FCM IV RUDIX FCM IV is indicated in the following medical conditions: 1. Iron Deficiency Anemia (IDA) Used when oral iron therapy is ineffective, poorly tolerated, or when rapid correction of anemia is required. 2. Chronic Kidney Disease (CKD) Patients with CKD often experience anemia due to reduced erythropoietin production and iron deficiency. IV iron helps restore iron levels efficiently. 3. Postpartum Anemia Women who experience significant blood loss during childbirth may require quick iron restoration. 4. Heavy Menstrual Bleeding For women with chronic blood loss leading to iron deficiency. 5. Gastrointestinal Disorders Conditions such as inflammatory bowel disease (IBD), celiac disease, or gastric surgery can impair iron absorption, making IV iron therapy necessary. 6. Pre- and Post-Surgical Patients Patients undergoing major surgeries may require rapid iron replenishment to improve recovery. Key Benefits of RUDIX FCM IV ✔ Rapid Iron Replenishment Allows administration of high doses in a single sitting, helping patients recover faster compared to oral supplements. ✔ Improved Patient Compliance Fewer hospital visits are required due to the ability to deliver larger doses in one infusion. ✔ Better Tolerability Lower incidence of gastrointestinal side effects compared to oral iron therapy. ✔ Controlled Iron Release The stable iron-carbohydrate complex reduces the risk of free iron reactions. ✔ Suitable for Multiple Patient Groups Safe for use in adults with various underlying medical conditions under medical supervision. ✔ Clinically Proven Effectiveness Helps improve hemoglobin levels, replenish iron stores, and reduce fatigue and weakness associated with anemia. Dosage and Administration RUDIX FCM IV should be administered only by qualified healthcare professionals in a clinical setting. The dosage depends on: Patient’s body weight Hemoglobin level Severity of iron deficiency Underlying medical condition It may be given as a slow intravenous injection or diluted in saline for infusion. Monitoring during and after administration is recommended to ensure patient safety. Possible Side Effects Like all medications, RUDIX FCM IV may cause side effects, although not everyone experiences them. Common Side Effects: Headache Nausea Dizziness Injection site reactions Flushing Less Common but Serious Reactions: Hypersensitivity reactions Hypotension (low blood pressure) Allergic reactions Shortness of breath Patients should be monitored during infusion. Immediate medical attention is required if signs of severe allergic reactions occur. Precautions and Warnings Should not be used in patients with known hypersensitivity to ferric carboxymaltose. Not recommended in patients with iron overload disorders such as hemochromatosis. Use cautiously in patients with liver dysfunction. Pregnancy and lactation use should be evaluated by a healthcare provider. Must be administered in facilities equipped to manage anaphylactic reactions. Storage Instructions Store at controlled room temperature. Protect from light. Do not freeze. Keep out of reach of children. Why Choose RUDIX FCM IV? RUDIX FCM IV stands out due to its high-quality formulation, safety profile, and effectiveness in treating iron deficiency anemia. It offers healthcare providers a reliable option for rapid correction of iron deficiency while minimizing patient inconvenience. Its ability to deliver higher doses in fewer sessions makes it a preferred choice in hospitals, nephrology clinics, gynecology practices, and surgical recovery units. Conclusion Iron deficiency anemia can significantly impact quality of life, causing fatigue, weakness, reduced immunity, and impaired cognitive function. Timely correction is essential to restore overall health and vitality.
